Takeda Pharmaceutical recently announced that the European Drug Administration (EMA) has accepted the declaration of its dengue vaccine TAK-003, which is developed for people between the ages of 4 and 60 toRead More…
At present, new antigen vaccines have become a hot direction in the field of cancer immunotherapy. With the release of some positive clinical data and more and more projects entering the clinicalRead More…
Inactivated and live attenuated vaccines usually produce sufficient immune responses and can be safely used in children with autoimmune diseases received all treated except the most effective immunosuppressants, according to a reviewRead More…
One of the reasons why it is so difficult to make effective vaccines against certain viruses, including influenza and HIV, is that these viruses mutate very quickly. This allows them to escapeRead More…
Recently, the clinical data on the treatment of two different types of WT1-positive (WT1+) advanced solid tumors with a new cancer vaccine galinpepimut-S (GPS) combined with immune checkpoint inhibitors were released. GPSRead More…
Respiratory syncytial virus (RSV) is the most common pathogen of viral pneumonia in children, which occurs mostly in newborns and infants less than 6 months old, as well as in immunodeficiency patientsRead More…
1. Type of vaccine Advances in virology, molecular biology, and immunology have created many alternatives to traditional vaccines. Modern vaccines include nucleic acid (mRNA, DNA) vaccines, viral vector vaccines, virus-like particles andRead More…
Vaccines can greatly prevent infectious diseases. Between 1924 and 2010, 103 million childhood diseases were prevented in the United States through vaccination alone. In particular, smallpox was eliminated by vaccines in 1980,Read More…
A tool designed to detect the history of viral infection from a drop of blood has been upgraded in the COVID-19 era. VirScan is a technique that determines which of more thanRead More…
In a new study, researchers from the University of North Carolina at Chapel Hill and other research institutions have developed a new COVID-19 mouse model that reproduces many of the features ofRead More…